Level of circulating microRNA-92a in patients with stable angina pectoris and type 2 diabetes mellitus

摘要：

Background The risk for development of CHD is 2-4 times higher in type 2 diabetes mellitus (T2DM) than in non-diabetics.Strategies capable of assessing changes in vascular endothelium at the preclinical stage hold potential to refine cardiovascular risk.MicroRNA-92a (miR-92a) was identified as an endogenous repressor of the angiogenic program in endothelial cells (ECs).This study focuses on the aberrant expression of miR-92a in patients with stable angina pectoris (SAP) and diabetes.

作者: WANG Hong LIN Ying-zhong GONG Guo-ping

作者单位: Department of Cardiology,Cuangxi People”s Hospital

会议类型: 国内会议

会议名称: 第11届中国介入心脏病学大会

会议地点: 北京

会议语种:英文

页码: 45-45

在线出版日期: 2013-03-20（万方平台首次上网日期，不代表论文的发表时间）